Supplemental Table 1. 5-year CIN of LR, metastasis, DSD, and major poor outcomes for all immunosuppressed, SOT, and CLL by BWH stage

Supplemental Table 1. 5-year cumulative incidence (CIN) of local recurrence (LR), metastasis, disease-specific death (DSD), and major poor outcomes (MPO) for all immunosuppressed (IS) patients, solid organ transplant (SOT) recipients, and chronic lymphocytic leukemia (CLL) patients by Brigham and Women’s Hospital (BWH) stage, with 95% confidence intervals (CI)